BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 24665856)

  • 1. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
    Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
    Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
    Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
    BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.
    Scholpa NE; Kolli RT; Moore M; Arnold RD; Glenn TC; Cummings BS
    Chem Biol Interact; 2016 Oct; 258():21-9. PubMed ID: 27543423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses
    Segatto NV; Simões LD; Bender CB; Sousa FS; Oliveira TL; Paschoal JDF; Pacheco BS; Lopes I; Seixas FK; Qazi A; Thomas FM; Chaki S; Robertson N; Newsom J; Patel S; Rund LA; Jordan LR; Bolt C; Schachtschneider KM; Schook LB; Collares TV
    Front Oncol; 2024; 14():1323422. PubMed ID: 38469237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation as a Therapeutic Target for Bladder Cancer.
    Nunes SP; Henrique R; Jerónimo C; Paramio JM
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating β-catenin signaling pathway.
    Man X; Liu T; Jiang Y; Zhang Z; Zhu Y; Li Z; Kong C; He J
    Onco Targets Ther; 2019; 12():6309-6322. PubMed ID: 31496734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of heat shock protein 90 inhibitors on histone 4 lysine 20 methylation in bladder cancer.
    Coban N; Varol N
    EXCLI J; 2019; 18():195-203. PubMed ID: 31217782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting DNA Methyltranferases in Urological Tumors.
    Marques-Magalhães Â; Graça I; Henrique R; Jerónimo C
    Front Pharmacol; 2018; 9():366. PubMed ID: 29706891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.
    Du Y; Wang Y; Zhang F; Wu W; Wang W; Li H; Xia S; Liu H
    Tumour Biol; 2015 Nov; 36(11):8839-44. PubMed ID: 26069102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.
    Chiurillo MA
    World J Exp Med; 2015 May; 5(2):84-102. PubMed ID: 25992323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.
    Valdez BC; Li Y; Murray D; Ji J; Liu Y; Popat U; Champlin RE; Andersson BS
    Exp Hematol; 2015 Jun; 43(6):448-61.e2. PubMed ID: 25704054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
    Varol N; Konac E; Bilen CY
    Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24).
    Varol N; Konac E; Onen IH; Gurocak S; Alp E; Yilmaz A; Menevse S; Sozen S
    DNA Cell Biol; 2014 Jul; 33(7):408-17. PubMed ID: 24665856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
    Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling pathway in non-small cell lung cancer.
    Stewart DJ
    J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.
    Camilli TC; Weeraratna AT
    Biochem Pharmacol; 2010 Sep; 80(5):702-11. PubMed ID: 20211149
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.